| A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn’s Ileitis Following the Suspension of Ursodeoxycholic Acid M Romeo, M Cipullo, G Iadanza, S Olivieri, AG Gravina, R Pellegrino, ... The American Journal of Case Reports 23, e936387-1, 2022 | | 2022 |
| A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to … P Chacon-Millan, S Lama, N Del Gaudio, AG Gravina, A Federico, ... International Journal of Molecular Sciences 25 (11), 5699, 2024 | | 2024 |
| Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study AG Gravina, A Federico, A Facchiano, G Scidà, R Pellegrino, G Palladino, ... Reviews on Recent Clinical Trials 17 (2), 97-102, 2022 | | 2022 |
| Author's reply:“Assessing ChatGPT and perplexity AI performance” R Pellegrino, AG Gravina Digestive and Liver Disease, 2024 | | 2024 |
| BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study R Pellegrino, G Pellino, L Selvaggi, F Selvaggi, A Federico, M Romano, ... Expert Review of Clinical Pharmacology 15 (10), 1243-1252, 2022 | 7 | 2022 |
| BOC. 01.12: MELANOCORTIN 3 AND 5 RECEPTORS ARE EXPRESSED IN THE COLON OF INFLAMMATORY BOWEL DISEASE PATIENTS AND SHOWA DIFFERENT IMMUNOHISTOCHEMICAL PROFILE THAT ACCOUNTS FOR … AG Gravina, R Pellegrino, I Panarese, MC Trotta, M D'Amico, ... Digestive and Liver Disease 56, S107-108, 2024 | | 2024 |
| Challenges in inflammatory bowel disease: current, future and unmet needs AG Gravina, R Pellegrino, F Zingone Frontiers in Medicine 9, 979535, 2022 | 3 | 2022 |
| Challenges in inflammatory bowel disease: current, future and unmet needs, volume II AG Gravina, R Pellegrino, G Bodini Frontiers in Medicine 10, 1326126, 2023 | | 2023 |
| Charting new AI education in gastroenterology: cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam AG Gravina, R Pellegrino, G Palladino, G Imperio, A Ventura, A Federico Digestive and Liver Disease, 2024 | 3 | 2024 |
| Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report. R Pellegrino, G Palladino, G Imperio, M Cipullo, A Federico, AG Gravina Minerva Medica, 2023 | | 2023 |
| Could Chat Generative Pre-Trained Transformer (ChatGPT) be an AI-provided friend of the patients for frequently asked questions concerning their IBD management? An evidence-and … AG Gravina, R Pellegrino, G Palladino, G Imperio, A Ventura, S Auletta, ... JOURNAL OF CROHNS & COLITIS 18, I927-I927, 2024 | | 2024 |
| Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric … AG Gravina, R Pellegrino, R De Micco, M Dellavalle, A Grasso, ... Frontiers in Medicine 10, 1233575, 2023 | 1 | 2023 |
| Efficacy of ustekinumab in the treatment of patients with Crohn’s disease with failure to previous conventional or biologic therapy: A prospective observational real-life study A Miranda, AG Gravina, A Cuomo, C Mucherino, D Sgambato, ... J. Physiol. Pharmacol 72, 5, 2021 | 9 | 2021 |
| Emerging space for non-polyethene-glycol bowel preparations in inflammatory bowel disease-related colonoscopy: Veering toward better adherence and palatability R Pellegrino, AG Gravina World Journal of Gastroenterology 29 (46), 6022, 2023 | 1 | 2023 |
| Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? R Pellegrino, V Nacca, F Paragliola, E Martinelli, A Federico, AG Gravina Minerva Medica 115, 1-3, 2024 | | 2024 |
| Erectile and sexual dysfunction in male and female patients with celiac disease: a cross‐sectional observational study L Romano, R Pellegrino, C Sciorio, B Barone, AG Gravina, ... Andrology 10 (5), 910-918, 2022 | 31 | 2022 |
| Evaluation of the efficacy and safety of a compound of micronized flavonoids in combination with vitamin C and extracts of centella asiatica, vaccinium myrtillus, and vitis … AG Gravina, R Pellegrino, A Facchiano, G Palladino, C Loguercio, ... Frontiers in Pharmacology 12, 773320, 2021 | 5 | 2021 |
| Hericium erinaceus, a medicinal fungus with a centuries-old history: evidence in gastrointestinal diseases AG Gravina, R Pellegrino, S Auletta, G Palladino, G Brandimarte, ... World Journal of Gastroenterology 29 (20), 3048, 2023 | 9 | 2023 |
| Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study AG Gravina, R Pellegrino, G Palladino, A Coppola, G Brandimarte, ... Frontiers in Immunology 14, 1215329, 2023 | 5 | 2023 |
| Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study AG Gravina, R Pellegrino, T Durante, G Palladino, R D’Onofrio, ... World Journal of Gastroenterology 29 (41), 5668, 2023 | 6 | 2023 |
